ArticleFrontiers in allergy2026
Clinical characteristics and severity of concomitant atopic dermatitis in adults with asthma: a nationwide population-based registry study.
Article in Frontiers in allergy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Atopic dermatitis (AD) often coexists with asthma, but the characteristics of AD in adults with asthma are largely unknown. Objective: The objective of this work was to examine the characteristics and severity of AD in adults with asthma. Methods: This population-based registry study identified adults (18-45 years) with an inpatient or outpatient asthma diagnosis in Danish hospitals between 1 January 2000 and 31 December 2019. AD history was determined by inpatient or outpatient diagnostic codes. AD and asthma severity were assessed through patient surveys using the Patient-Oriented SCORing Atopic Dermatitis (PO-SCORAD) and the Global Initiative for Asthma (GINA) 2024. Results: Among 4,126 patients (15% response rate), 5.2% had AD. Of these, 22.7% were treated with GINA Step 4-5. Patients with AD were primarily women (74.3%) with childhood-onset AD (90.7%) and asthma (82.6%, Conclusions: Asthma patients with AD often have childhood onset of both conditions and mild-to-moderate AD. Clinicians should recognize that AD in high-burden skin areas is common in asthma patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.